company background image
BSX logo

Boston Scientific DB:BSX Stock Report

Last Price

€63.62

Market Cap

€93.3b

7D

4.0%

1Y

41.3%

Updated

28 Mar, 2024

Data

Company Financials +

Boston Scientific Corporation

DB:BSX Stock Report

Market Cap: €93.3b

BSX Stock Overview

Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide.

BSX fundamental analysis
Snowflake Score
Valuation1/6
Future Growth3/6
Past Performance4/6
Financial Health4/6
Dividends0/6

Boston Scientific Corporation Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Boston Scientific
Historical stock prices
Current Share PriceUS$63.62
52 Week HighUS$63.62
52 Week LowUS$45.03
Beta0.78
1 Month Change3.99%
3 Month Change23.73%
1 Year Change41.28%
3 Year Change93.96%
5 Year Change86.95%
Change since IPO546.25%

Recent News & Updates

Recent updates

Shareholder Returns

BSXDE Medical EquipmentDE Market
7D4.0%2.4%2.5%
1Y41.3%7.2%7.0%

Return vs Industry: BSX exceeded the German Medical Equipment industry which returned 7.2% over the past year.

Return vs Market: BSX exceeded the German Market which returned 7% over the past year.

Price Volatility

Is BSX's price volatile compared to industry and market?
BSX volatility
BSX Average Weekly Movement2.5%
Medical Equipment Industry Average Movement5.0%
Market Average Movement4.8%
10% most volatile stocks in DE Market10.1%
10% least volatile stocks in DE Market2.4%

Stable Share Price: BSX has not had significant price volatility in the past 3 months.

Volatility Over Time: BSX's weekly volatility (3%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
197948,000Mike Mahoneyhttps://www.bostonscientific.com

Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through two segments, MedSurg and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions, such as resolution clips, biliary stent systems, stents and electrocautery enhanced delivery systems, direct visualization systems, digital catheters, and single-use duodenoscopes; devices to treat urological conditions, including ureteral stents, catheters, baskets, guidewires, sheaths, balloons, single-use digital flexible ureteroscopes, holmium laser systems, artificial urinary sphincter, laser system, fiber, and hydrogel systems; and devices to treat neurological movement disorders and manage chronic pain, such as spinal cord stimulator system, proprietary programming software, radiofrequency generator, indirect decompression systems, practice optimization tools, and deep brain stimulation system.

Boston Scientific Corporation Fundamentals Summary

How do Boston Scientific's earnings and revenue compare to its market cap?
BSX fundamental statistics
Market cap€93.32b
Earnings (TTM)€1.46b
Revenue (TTM)€13.20b

64.0x

P/E Ratio

7.1x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
BSX income statement (TTM)
RevenueUS$14.24b
Cost of RevenueUS$4.39b
Gross ProfitUS$9.85b
Other ExpensesUS$8.28b
EarningsUS$1.57b

Last Reported Earnings

Dec 31, 2023

Next Earnings Date

n/a

Earnings per share (EPS)1.07
Gross Margin69.16%
Net Profit Margin11.03%
Debt/Equity Ratio46.6%

How did BSX perform over the long term?

See historical performance and comparison
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.